Exhibit 99.1 TOYS "R" US/BABIES "R" US PROMOTION AGREEMENT This Promotion Agreement ("Agreement") between Toys "R" Us - Delaware, Inc. ("TRU") and RED GIANT ENTERTAINMENT, INC ("Partner") (each of TRU and Partner, a "Party") is effective as of JUNE...Promotion Agreement • July 11th, 2014 • Red Giant Entertainment, Inc. • Books: publishing or publishing & printing • New Jersey
This Promotion Agreement ("Agreement") between Toys "R" Us - Delaware, Inc. ("TRU") and RED GIANT ENTERTAINMENT, INC ("Partner") (each of TRU and Partner, a "Party") is effective as of JUNE 16, 2014.
Co-promotion agreement for Exenatide once-weeklyPromotion Agreement • November 8th, 2022 • New York
First amendment to development, supply, manufacturing, licensing, promotion, and loan agreement for Exenatide once-weekly Development, supply, manufacturing, licensing, promotion, and loan agreement for Exenatide once-weekly (terminated)
AMENDED AND RESTATED PROMOTION AGREEMENT BETWEEN NOVARTIS PHARMACEUTICALS CORPORATION AND RELIANT PHARMACEUTICALS, INC.Promotion Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • New Jersey
CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. SUCH OMISSIONS DENOTED WITH [***].Promotion Agreement • December 5th, 2014 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • Delaware
This Master Program Services and Product Co-Promotion Agreement (this “Agreement”) is made and entered into effective as of June 10, 2014 (the “Effective Date”) by and between ORASURE TECHNOLOGIES, INC., a Delaware corporation having a principal place of business at 220 East First Street, Bethlehem, Pennsylvania 18015 (“OraSure”), and ABBVIE BAHAMAS LTD. a Bahamian limited corporation having a principal place of business at Sassoon House, Shirley Street & Victoria Avenue, PO Box SS-5383, Nassau, New Providence, Bahamas (“AbbVie”). OraSure and AbbVie are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
RECITALSPromotion Agreement • August 9th, 2005 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • New York
JUNE 25, 2007-Promotion Agreement • August 9th, 2007 • Critical Therapeutics Inc • Pharmaceutical preparations • New York
PROMOTION AGREEMENTPromotion Agreement • August 8th, 2008 • Depomed Inc • Pharmaceutical preparations • California
This PROMOTION AGREEMENT (this “Agreement”) is made as of July 21, 2008 (the “Effective Date”), by and between Depomed, Inc., a California corporation (“Depomed”), and Santarus, Inc., a Delaware corporation (“Santarus”). Each of Depomed and Santarus is referred to herein individually as a “party” and collectively as the “parties.”
Oberon Media, INC. SOFTWARE PRODUCT LICENSING AND SOFTWARE GAME DISTRIBUTION AND PROMOTION AGREEMENTPromotion Agreement • January 26th, 2006 • IncrediMail Ltd. • Services-computer programming services
This Software Product Licensing, and Game Software Distribution and Promotion Agreement (this “Agreement”) is effective as of, Jan 7th 2004 (the “Effective Date”), by and between Oberon Media, Inc., a Delaware corporation further described below (“Licensor”), and IncrediMail, Ltd., a Software corporation, located at Tel Aviv Israel (“Partner”), and describes the terms and conditions relating to Partner’s use, distribution and promotion of Licensor’s game software and other software products.
RECITALS-Promotion Agreement • January 31st, 2001 • Omp Inc • Pharmaceutical preparations • New Jersey
ContractPromotion Agreement • October 27th, 2010 • Zogenix, Inc. • Pharmaceutical preparations • New York
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
BETWEENPromotion Agreement • November 13th, 1998 • Warner Chilcott PLC • Pharmaceutical preparations • New Jersey
PROMOTION AGREEMENTPromotion Agreement • June 11th, 2002 • Healthetech Inc • Surgical & medical instruments & apparatus • Colorado
This Promotion Agreement ("Agreement") is made and entered into as of this 23rd day of May, 2002 ("Effective Date"), by and between HealtheTech, Inc., a Delaware corporation having its principal place of business at 523 Park Point Drive, Third Floor, Golden, Colorado 80401 USA ("HET"), and HEALTHSOUTH Corporation, located at One Healthsouth Parkway, Birmingham, Alabama 35243 ("HS").
CONFIDENTIAL TREATMENT AMENDED AND RESTATED PROMOTION AGREEMENTPromotion Agreement • December 7th, 2010 • KAYAK SOFTWARE Corp • Services-business services, nec • New York
This AMENDED AND RESTATED PROMOTION AGREEMENT (this “Agreement”) is dated as of April 23, 2009, and effective January 1, 2009 (the “Effective Date”) by and between Kayak Software Corp. (“Kayak”), a Delaware corporation with offices at 55 North Water Street, Suite 1, Norwalk, Connecticut 06854, and Orbitz Worldwide, LLC (“Orbitz”), a Delaware corporation with offices at 500 West Madison Street, Suite 1000, Chicago, IL 60661.
FIRST AMENDMENT TO PROMOTION AGREEMENTPromotion Agreement • August 14th, 2002 • Questcor Pharmaceuticals Inc • Pharmaceutical preparations • New York
This FIRST AMENDMENT TO PROMOTION AGREEMENT (the “Amendment”) is made as of June 27, 2002, by and between QUESTCOR PHARMACEUTICALS, INC., a California Corporation (“Questcor”), and VSL PHARMACEUTICALS, INC., a Delaware corporation(“VSL”).
Exhibit 10.5 CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CO-PROMOTION...-Promotion Agreement • November 12th, 2004 • Santarus Inc • Pharmaceutical preparations • New York
CO-PROMOTION AGREEMENTPromotion Agreement • August 13th, 2018 • Jaguar Health, Inc. • Pharmaceutical preparations • New York
THIS CO-PROMOTION AGREEMENT is made and entered into as of June 28, 2018 (the “Effective Date”), by and between Napo Pharmaceuticals, Inc., a California company, having a place of business at 201 Mission Street Suite 2375 San Francisco, CA 94105, USA and all Affiliates thereof (“Napo”) and RedHill Biopharma, Inc., a Delaware corporation, having an address at 8045 Arco Corporate Drive, Suite 120, Raleigh, North Carolina 27617 and all Affiliates thereof (“RedHill”). RedHill and Napo each may be referred to herein individually as a “Party,” or collectively as the “Parties.”
DESCRIPTION OFPromotion Agreement • March 11th, 2004 • Amgen Inc • Biological products, (no disgnostic substances)
CO-PROMOTION AGREEMENTPromotion Agreement • August 25th, 2010 • Somaxon Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This PROMOTION AGREEMENT (this “Agreement”) is made as of August 24, 2010 (the “Effective Date”), by and between The Procter & Gamble Distributing Company LLC, a Delaware limited liability company (“Partner”), and Somaxon Pharmaceuticals, Inc., a Delaware corporation (“Somaxon”). Each of Somaxon and Partner is referred to herein individually as a “party” and collectively as the “parties.”
IA Institute Event Promotion AgreementPromotion Agreement • October 3rd, 2011
Thank you choosing to promote your event through the Information Architecture Institute. This letter outlines our proposal for a Community Partner promotional arrangement. Please direct all questions to events@IA Institutenstitute.org.
PROMOTION AGREEMENT (the “Agreement”)Promotion Agreement • December 3rd, 2009 • On4 Communications Inc. • Services-prepackaged software • Ontario
COLOGUARD® PROMOTION AGREEMENT BY AND BETWEEN EXACT SCIENCES CORPORATION AND PFIZER INC. August 21, 2018Promotion Agreement • August 22nd, 2018 • Exact Sciences Corp • Services-commercial physical & biological research • New York
This Agreement (the “Agreement”) is made and entered into as of August 21, 2018 (the “Effective Date”), by and between Pfizer Inc. (“Pfizer”), a Delaware corporation, with a principal place of business at 235 East 42nd Street, New York, New York 10017 and Exact Sciences Corporation (“Exact”), a Delaware corporation with a principal place of business at 441 Charmany Drive, Madison, Wisconsin 53719. Pfizer and Exact may each be referred to herein individually as a “Party” and collectively as the “Parties”.
PROMOTION AGREEMENT by and between DEPOMED, INC. and KING PHARMACEUTICALS, INC. Dated as of June 27, 2006 Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application...Promotion Agreement • August 9th, 2006 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
This PROMOTION AGREEMENT (this “Agreement”) is made as of June 27, 2006 (the “Effective Date”), by and between Depomed, Inc., a California corporation (“Depomed”), and King Pharmaceuticals, Inc., a Tennessee corporation (“King”). Each of Depomed and King is referred to herein individually as a “party” and collectively as the “parties.”
PROMOTION AGREEMENTPromotion Agreement • September 14th, 2015 • VNUE, Inc. • Metal mining • Nevada
This Promotion Agreement (“Agreement”) is entered into effective September 10, 2015 between BookingEntertainment.com (“Promoter”) of 275 Madison Avenue, 6th Floor, New York, NY 10016 and VNUE, Inc., (“VNUE”), a Nevada corporation quoted on the OTCMarkets, with offices at
Addendum to September 19, 2002Promotion Agreement • July 31st, 2008 • Amylin Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Addendum to the U.S. Co-Promotion Agreement (the “Addendum”) is made effective as of the 8th day of May, 2008 (the “Effective Date”) by and between Amylin Pharmaceuticals, Inc. (“Amylin”), a Delaware corporation having its principal place of business at 9360 Towne Center Drive, San Diego, California, 92121.
AMENDED AND RESTATED PROMOTION AGREEMENT BETWEEN NOVARTIS PHARMACEUTICALS CORPORATION AND RELIANT PHARMACEUTICALS, INC.Promotion Agreement • June 6th, 2005 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • New Jersey
This AMENDED AND RESTATED PROMOTION AGREEMENT, dated and effective the 5th day of April, 2005 (this “Agreement”), is made by and between Novartis Pharmaceuticals Corporation, a Delaware corporation, having offices at 59 Route 10, East Hanover, New Jersey 07936 (hereinafter “Novartis”) and Reliant Pharmaceuticals, Inc., a Delaware corporation (f/k/a Reliant Pharmaceuticals, LLC), having offices at 110 Allen Road, Liberty Corner, New Jersey 07938 (hereinafter “Reliant”).
AMENDED AND RESTATED PROMOTION AGREEMENTPromotion Agreement • November 8th, 2007 • Depomed Inc • Pharmaceutical preparations • New York
This AMENDED AND RESTATED PROMOTION AGREEMENT (this “Agreement”) is made as of September 21, 2007 (the “Effective Date”), by and between Depomed, Inc., a California corporation (“Depomed”), and Watson Pharma, Inc., a Delaware corporation (“Watson”). Each of Depomed and Watson is referred to herein individually as a “Party” and collectively as the “Parties”.
EXHIBIT 10.1 SECOND AMENDMENT TO PROMOTION AGREEMENT --------------------------------------- This Amendment to the Promotion Agreement between SCHERING CORPORATION ("Schering") and WARNER CHILCOTT PLC ("Warner Chilcott"), effective July 1, 1998 and...Promotion Agreement • August 13th, 1999 • Warner Chilcott PLC • Pharmaceutical preparations
LEICESTERSHIRE COUNTY COUNCIL (ASHBY DE LA ZOUCH CANAL EXTENSION) ORDER [DRAFT] PROMOTION AGREEMENTPromotion Agreement • February 4th, 2003
THIRD AMENDMENT TO PROMOTION AGREEMENTPromotion Agreement • March 20th, 2023 • Liquidia Corp • Pharmaceutical preparations • New York
This Third Amendment to Promotion Agreement (this “Third Amendment”), is entered into as of November 18, 2022 (the “Third Amendment Effective Date”) by and between Sandoz Inc. (“Sandoz”) and Liquidia PAH, LLC, formerly known as RareGen, LLC (“RareGen”).
PROMOTION AGREEMENT NUMBER 3 DATED May 16, 2012Promotion Agreement • May 25th, 2012
This Promotion Agreement is attached to the License Agreement entered into between Sony Network Entertainment International LLC (“Licensee”) and Culver Digital Distribution Inc. (“Licensor”) dated October 15, 2010.
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE EXAGEN INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO EXAGEN INC. IF PUBLICLY DISCLOSED....-Promotion Agreement • August 23rd, 2019 • Exagen Inc. • Services-medical laboratories • New York
This Co-Promotion Agreement (this “Agreement”) is signed as of the signature date(s) below and made effective as of December 10, 2018 (the “Effective Date”) by and between Janssen Biotech, Inc., with offices at 800 Ridgeview Drive, Horsham, PA 19044 (“JBI”), and Exagen Diagnostics Inc., with offices at 1261 Liberty Way, Suite C, Vista CA 92081 (“Exagen”).
BY AND BETWEEN ZYMOGENETICS, INC. AND BAYER HEALTHCARE LLC EFFECTIVE AS OF JUNE 18, 2007 the Securities and Exchange Commission pursuant to a request for confidential treatment.Promotion Agreement • August 1st, 2007 • Zymogenetics Inc • Biological products, (no disgnostic substances) • New York
THIS U.S. CO-PROMOTION AGREEMENT is made as of the 18th day of June, 2007 (the “Effective Date”) by and between ZymoGenetics, Inc., a corporation organized and existing under the laws of Washington State, U.S.A. (“ZGEN”), and Bayer HealthCare LLC, a limited liability company organized and existing under the laws of Delaware (“Bayer”). ZGEN and Bayer are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
FIRST AMENDMENT TO MASTER PROGRAM SERVICES AND PRODUCT CO-PROMOTION AGREEMENT-Promotion Agreement • July 1st, 2016 • Orasure Technologies Inc • Surgical & medical instruments & apparatus
This First Amendment to Master Program Services and Product Co-Promotion Agreement (this “Amendment”), between OraSure Technologies, Inc., a Delaware corporation, having its principal place of business at 220 East First Street, Bethlehem, PA 18015 (“OraSure”), and AbbVie Bahamas Ltd., a Bahamian limited corporation, having its principal place of business at Sassoon House, Shirley Street & Victoria Avenue, PO Box SS-5383, Nassau, New Providence, Bahamas (“AbbVie”), is entered into as of June 30, 2016. Both AbbVie and OraSure may be referred to herein individually as a “Party” and collectively as the “Parties”.
AMENDMENT NO. 3 TO AMENDED AND RESTATED PROMOTION AGREEMENTPromotion Agreement • May 4th, 2005 • Amgen Inc • Biological products, (no disgnostic substances)
This Amendment No. 3 (this “Amendment”), entered into as of this 19th day of April, 2005 and effective as of the 1st day of January, 2005 (the “Effective Date”), is made by and among Wyeth, a Delaware corporation (formerly American Home Products Corporation, “Wyeth”), Amgen Inc., a Delaware corporation (“Amgen”), and Immunex Corporation, a Washington corporation and wholly-owned subsidiary of Amgen (“Immunex”) and amends the Amended and Restated Promotion Agreement dated as of December 16, 2001 which became effective on July 15, 2002, as amended by Amendment No. 1 to Collaboration and Global Supply Agreement, Amended and Restated Promotion Agreement, and TNFR License and Development Agreement effective as of July 8, 2003 among Wyeth, Amgen and Immunex and by Amendment No. 2 to Collaboration and Global Supply Agreement and Amended and Restated Promotion Agreement effective as of April 20, 2004 among Wyeth, Amgen and Immunex (as amended, the “Promotion Agreement”).
PROMOTION AGREEMENTPromotion Agreement • June 20th, 2005 • SLS International Inc • Household audio & video equipment
This Promotion Agreement (this “Agreement”) is entered into and made effective as of June 14, 2005, by and among SLS International, Inc., a Delaware corporation (“SLS”), JMBP, Inc. (“JMBP”), a California corporation, and Mark Burnett (“Burnett” and, together with SLS and JMBP, the “Parties”). In consideration of the mutual agreements set forth herein and for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows:
